Project Description
Henlez
Disruptive treatment of follicular occlusion disorders
Develops potent, stable enzymes for topical application to treat dermatological conditions.
Primary focus is on acne-like disorders such as Acne vulgaris and Hidradenitis suppurativa.
Henlez is based in Copenhagen, Denmark and is headed by founder and CEO Jeppe Mouritsen
Henlez joined NOME in 2021.
